Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1958 1
1959 1
1961 1
1962 1
1963 1
1965 1
1966 5
1967 6
1968 8
1969 7
1970 5
1971 10
1972 5
1973 7
1974 20
1975 13
1976 9
1977 10
1978 9
1979 10
1980 22
1981 24
1982 20
1983 29
1984 30
1985 37
1986 52
1987 63
1988 79
1989 70
1990 60
1991 66
1992 76
1993 93
1994 106
1995 96
1996 95
1997 95
1998 107
1999 110
2000 105
2001 112
2002 97
2003 91
2004 81
2005 92
2006 80
2007 118
2008 109
2009 82
2010 94
2011 70
2012 87
2013 87
2014 91
2015 96
2016 108
2017 122
2018 116
2019 107
2020 131
2021 141
2022 135
2023 12
Text availability
Article attribute
Article type
Publication date

Search Results

3,576 results
Results by year
Filters applied: . Clear all
Page 1
Interleukin-11-expressing fibroblasts have a unique gene signature correlated with poor prognosis of colorectal cancer.
Nishina T, Deguchi Y, Ohshima D, Takeda W, Ohtsuka M, Shichino S, Ueha S, Yamazaki S, Kawauchi M, Nakamura E, Nishiyama C, Kojima Y, Adachi-Akahane S, Hasegawa M, Nakayama M, Oshima M, Yagita H, Shibuya K, Mikami T, Inohara N, Matsushima K, Tada N, Nakano H. Nishina T, et al. Among authors: nakano h. Nat Commun. 2021 Apr 16;12(1):2281. doi: 10.1038/s41467-021-22450-3. Nat Commun. 2021. PMID: 33863879 Free PMC article.
Daratumumab in first-line therapy is cost-effective in transplant-eligible patients with newly diagnosed myeloma.
Yamamoto C, Minakata D, Koyama S, Sekiguchi K, Fukui Y, Murahashi R, Nakashima H, Matsuoka S, Ikeda T, Kawaguchi SI, Toda Y, Ito S, Nagayama T, Umino K, Nakano H, Morita K, Yamasaki R, Ashizawa M, Ueda M, Hatano K, Sato K, Ohmine K, Fujiwara SI, Kanda Y. Yamamoto C, et al. Among authors: nakano h. Blood. 2022 Aug 11;140(6):594-607. doi: 10.1182/blood.2021015220. Blood. 2022. PMID: 35580269
Clinical association between thyroid disease and immune thrombocytopenia.
Ito S, Fujiwara SI, Murahashi R, Nakashima H, Matsuoka S, Ikeda T, Kawaguchi SI, Toda Y, Ban T, Nagayama T, Umino K, Minakata D, Morita K, Nakano H, Yamasaki R, Ashizawa M, Yamamoto C, Hatano K, Sato K, Oh I, Ohmine K, Kanda Y. Ito S, et al. Among authors: nakano h. Ann Hematol. 2021 Feb;100(2):345-352. doi: 10.1007/s00277-020-04343-5. Epub 2020 Nov 9. Ann Hematol. 2021. PMID: 33165625 Clinical Trial.
Targeting FROUNT with disulfiram suppresses macrophage accumulation and its tumor-promoting properties.
Terashima Y, Toda E, Itakura M, Otsuji M, Yoshinaga S, Okumura K, Shand FHW, Komohara Y, Takeda M, Kokubo K, Chen MC, Yokoi S, Rokutan H, Kofuku Y, Ohnishi K, Ohira M, Iizasa T, Nakano H, Okabe T, Kojima H, Shimizu A, Kanegasaki S, Zhang MR, Shimada I, Nagase H, Terasawa H, Matsushima K. Terashima Y, et al. Among authors: nakano h. Nat Commun. 2020 Jan 30;11(1):609. doi: 10.1038/s41467-020-14338-5. Nat Commun. 2020. PMID: 32001710 Free PMC article.
Development of Xenoturbellida.
Nakano H. Nakano H. Results Probl Cell Differ. 2019;68:251-258. doi: 10.1007/978-3-030-23459-1_11. Results Probl Cell Differ. 2019. PMID: 31598860 Review.
Familial Michelin tire baby syndrome.
Hayashi M, Wataya-Kaneda M, Koguchi-Yoshioka H, Arase N, Kubo T, Nakano H, Fujimoto M. Hayashi M, et al. Among authors: nakano h. J Dermatol. 2022 Jul;49(7):e219-e220. doi: 10.1111/1346-8138.16346. Epub 2022 Mar 11. J Dermatol. 2022. PMID: 35277884 No abstract available.
3,576 results